46
Views
14
CrossRef citations to date
0
Altmetric
Research Article

OCHRATOXIN A IN THE CZECH REPUBLIC

, , , , , , , , , & show all
Pages 261-274 | Published online: 30 Nov 2001

REFERENCES

  • van der Merwe K. J., Steyn P. S., Fourie L. Mycotoxins Part II. The constitution of ochratoxins A, B and C, metabolites of Aspergillus ochraceus. Wilh. J. Chem. Soc. 1965b; 7083–7088
  • van der Merwe K. J., Steyn P. S., Fourie L. Ochratoxin A, a toxic metabolite produced by Aspergillus ochraceus. Wilh. Nature 1965a; 205(4976)1112–1113
  • Steyn P. S., Holzapfel C. W. The synthesis of ochratoxins A and B, metabolites of Aspergillus ochraceus. Wilh. Tetrahedron 1967b; 23: 4449–4461
  • Creppy E. E., Dirheimer G. Toxicité de l'ochratoxine A, une mycotoxine contaminant les aliments de l'homme et de l'animal. Cah Nutr. Diet 1991; 26(5)342–348
  • Pittet A. Natural occurrence of mycotoxins in foods and feeds—an updated review. Revue Méd. Vét. 1998; 149(6)479–492
  • Pitt J. I. Penicillium viridicatum, Penicillium verrucosum and production of ochratoxin. A. Appl. Environ. Microbiol. 1987; 53: 266–269
  • Trenk H. L., Butz M. E., Chu F. S. Production of ochratoxin A in different cereal products by Aspergillus ochraceus. Appl. Microbiol. 1991; 21: 1032–1035
  • Mislivec P. B., Tuite J. Temperature and relative humidity requirements of species of Penicillium isolated from yellow dentcorn kernels. Mycologia 1970; 62: 75–88
  • Pohland A. E., Nesheim S., Friedman L. Ochratoxin A, a review. Pure Appl. Chem. 1992; 64: 1029–1046
  • Assessment of dietary intake of ochratoxin A by the population of EU member. Reports on tasks for scientific cooperation. EUR Report 17523 (1999). Official Publications of the EC, Luxembourg
  • Creppy E. E. Human ochratoxicosis. J. Toxicol.-Toxin Reviews 1999; 18(3-4)277–293
  • Baudrimont I. Variation de la nephrotoxicité de l'ochratoxine A sous l'effet de facteurs métaboliques et nonmétaboliques Thèse pour le Doctorat (No. 2). Université II, Bordeaux 1995; 1–236
  • Rosa C. A.R., Santana D. M.N., Fraga M. E., Sabaa-Srur A. O.U. Ochratoxin A detection by immunoaffinity clean-up and HPLC in grape juice and wine samples sold in Rio de Janeiro, Brazil. Proceedings of 10th International IUPAC symposium on mycotoxins and phycotoxins, Guaruja, Sao PauloBrazil, 2000; 85
  • Bunge I., Heller K., Roschenthaler R. Isolation and purification of ochratoxin. A. Z. Lebensm. Unters. Forsch. 1979; 168: 457–458
  • Creppy E. E., Roschenthaler R., Dirheimer G. Inhibition of protein synthesis in mice by ochratoxin A and its prevention by phenylalanine. Food Chem. Toxicol. 1984; 22(11)883–886
  • Meisner H., Meisner P. Ochratoxin A, in vivo inhibitor of renal phosphoenolpyruvate carboxykinase. Arch. Biochem. Biophys. 1981; 208: 146–153
  • Rahimtula A. D., Bereziat J. C., Bussachini-Griot V., Bartsch H. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem. Pharmacol. 1988; 37: 4469–4477
  • Baudrimont I., Ahouandjivo R., Creppy E. E. Prevention of lipid peroxidation induced by ochratoxin A in Vero cells in culture by several agents. Chem. Biol. Int. 1997; 104: 29
  • Baudrimont I. Abstract “Mycotoxin TECHAGRO Workshop”. BrnoCzech Republic, April, 222000
  • IARC Monographs on the evaluation of carcinogenic risks to humans. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC, Lyon 1993; 56: 489–524
  • Gekle M., Silbernagl S. Mechanism of ochratoxin A-induced reduction of glomerular filtration rate in rats. J. Pharmacol. Exp. Ther. 1993; 267: 316–321
  • Gekle M., Pollock C. A., Silbernagl S. Time and concentration-dependent biphasic effect of ochratoxin A on growth of proximal tubular cells in primary culture. J. Pharmacol. Exper. Ther. 1995; 275(1)397–404
  • Gekle M., Silbernagl S. The role of proximal tubule in ochratoxin A nephrotoxicity in vivo: toxodynamic and toxokinetic aspects. Renal Physiol. Biochem. 1994; 17(1)40–49
  • Kuramochi G., Gekle M., Silbernagl S. Ochratoxin A disturbs pH homeostasis in the kidney: increases in pH and HCO3—in the tubules and vasa recta. Pflugers Arch. 1997; 434(4)392–397
  • Gekle M., Silbernagl S. Renal toxicodynamics of ochratoxin A: a pathophysiological approach. Kidney Blood Press Res. 1996; 19(5)225–235
  • Kozaczynski W. Experimental ochratoxicosis A in chickens. Histopatological and histochemical study. Arch. Vet. Pol. 1994; 34(3/4)205–219
  • Atroshi F., Biese I., Saloniemi H., Ali-Vehmas T., Saari S., Rizzo A., Veijalainen P. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharmaceut Sci 2000; 3(3)281–291, (www.ualberta.ca/-csps)
  • Castegnaro M., Bartsch H., Chernozemsky I. N. Endemic nephropathy and urinary tract tumours in the Balkans. Cancer Res. 1987; 47: 3608–3609
  • Malir F., Cerna M., Severa J., Jergeova Z. Ochratoxin A-toxicological importance, exposure of humans and health risk (in Czech). Hygiena 1998; 43(1)49–62
  • Di Paolo N., Guarnieri A., Loi F., Sacchi G., Mangiarotti A. M., Di Paolo M. Acute renal failure from inhalation of mycotoxins. Nephron 1993; 64: 621–625
  • Ruprich J., Ostry V. Health risk assessment of the mycotoxin ochratoxin A to humans: Czech Republic, Brno, 1991/1992. Cent. Eur. J. Public Health 1993; 1(2)86–93
  • Wafa E. W., Yahya R. S., Sobh M. A., Eraky I., El-Baz M., Ham El-Gyar, Betbeder A. M., Creppy E. E. Human ochratoxicosis and nephropathy in Egypt: A preliminary study. Hum. & Experim. Toxicol. 1999; 17: 124–129
  • Apostolou E., El-Nezami H. S., Ahokas J. T., Donohue D. C. The evaluation of ochratoxin A in breast milk in Victoria (Australia). Revue Méd. Vét. 1998; 149(6)709
  • Hult K., Plestina R., Habazin-Novak V., Radic B., Ceovic S. Ochratoxin A in human blood and Balkan Endemic Nephropathy. Arch. Toxicol. 1982b; 51: 313–321
  • Fuchs S., Radic B., Ceovic S., Sostaric B., Hult K. Human exposure to ochratoxin A. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. 115, IARC Scientific Publications, IARC, Lyon 1991; 115: 131–135
  • Petkova-Bocharova T., Castegnaro M. Ochratoxin A contamination of cereals in an area of high incidence of Balkan Endemic Nephropathy in Bulgaria. Food Additives and Contaminants 1985; 2(4)267–270
  • Petkova-Bocharova T., Chernozemsky I. N., Castegnaro M. Ochratoxin A in human blood in relation to Balkan Endemic Nephropathy and urinary systém in Bulgaria. Food Addit. Contam. 1998; 5: 299–301
  • Petkova-Bocharova T., Castegnaro M. Ochratoxin A in human blood in relation to Balkan endemic nephropathy and urinary tract tumours in Bulgaria. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. 115, IARC Scientific Publications, IARC, Lyon 1991; 135–137
  • Hald B. Ochratoxin in human blood in European countries. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. 115, IARC Scientific Publications, IARC, Lyon 1991; 159–164
  • Creppy E. E., Castegnaro M., Grosse Y., Mériaux J., Moncharmont P., Waller C., et coll. Etude de l'ochratoxicose humaine dans trois régions de France: Alsace Aquitaine et région Rhõne—Alpes. Human ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey Eurotext, LondonUnited Kingdom 1993; 231: 147–158
  • Breitholtz-Emanuelsson A., Minervini F., Hult K., Visconti A. Ochratoxin A in human serum samples collected in southern Italy from healthy individuals and individuals suffering from different kidney disorders. Nat. Toxins 1994; 2: 366–370
  • Bauer J., Gareis M. Ochratoxin A in der Nahrungsmittelkette. J. Vet. Med. 1987; 34: 613–627
  • Scheuer R., Leistner L. Occurrence of ochratoxin A in pork products. Proc. Eur. Meet. Meat Res. Work 1986; 32: 191–195
  • Hadlock R. M. Human ochratoxicosis in Germany: updating 1993. Human ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey Eurotext, LondonUnited Kingdom 1993; 231: 141–145
  • Golinski P., Grabatkiewicz-Szczenasna J. The first Polish cases of the detection of ochratoxin A residues in human bloods. Rocz. Panstw. Zakl. Hig. 1985; 36: 378–385
  • Golinski P., Grabatkiewicz-Szczenasna J., Chelkowski J., Hult K., Kostecki M. Possible sources of ochratoxin A in human blood. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. IARC Scientific Publications, IARC, Lyon 1991; 115: 153–157
  • Breitholtz A., Olsen M., Dahlbäck A., Hult K. Plasma ochratoxin A levels in three Swedish populations surveyed using an ion-pair HPLC technique. Food Addit. Contam. 1991; 8: 183–192
  • Vesela D., Vesely D., Jelinek S., Kusak V. Finding of ochratoxin A in the feed barley (in Czech). Veter. Med. 1978; 23: 431–436
  • Ruprich J., Piskac A., Mala J. Radioimmunoassay determination of mycotoxin ochratoxin A for screening control of food commodities of vegetable origin and feed cereals (in Czech). Veter. Med. 1988; 33: 165–173
  • Vesela D., Vesely D., Fassatiova O. Findings of toxinogenic moulds from Fusarium and Alternaria genera in wheat stocked (in Czech). Sbornik úVTIZ/Ochrana rostlin 1982; 18: 253–258
  • Ruprich J. Mycotoxin ochratoxin A, evaluation of the dangerousness and of health risk assessment (in Czech), Acta Hyg. Epid. Microbiol. 1997, Suppl. 6: 1–134
  • Speijers G. J.A., van Egmond H. P. Worldwide ochratoxin A levels in food and feeds. Human ochratoxicosis and its Pathologies, E. E. Creppy, M. Castegnaro, G. Dirheimer. Colloque INSERM/John Libbey Eurotext, LondonUnited Kingdom 1993; 231: 85–100
  • Krogh P. Ochratoxins in food. Mycotoxins in food, P. Krogh. Academic Press. 1987; 97–121
  • Ostry V., Ruprich J. 1997, Suppl. 3: 1–12, Assessment of dietary exposure to choice mycotoxins in CR (in Czech), Zpravy centra hygieny potravinovych retezcu, National Institute of Public Health, Brno
  • Ostry V., Ruprich J. 1999; 8(1)16–17, Determination of ochratoxin A in coffee and assessment of dietary exposure for population in Czech Republic (in Czech), Zpravy centra hygieny potravinovych retezcu, National Institute of Public Health, Brno
  • Ostry V., Ruprich J., Prochazkova I., Skarkova J., Ciprova J. Mycomon—determination of toxinogenic moulds in aliments (in Czech). Sbornik 5, konference monitoringu zdravotniho stavu ve vztahu k zivotnim podminkam. october, 3–52000, 15
  • Ostry V. Ochratoxin A in raisins 23. Mycotoxin Workshop. Personal communication, Wien, May, 28–302001
  • Piskac A., Halouzka R., Drabek J., Mala J., Smrcek C. Mycotoxic pig's nephropathy in pig-breeding of a large capacity (in Czech). Veterinarstvi 1979; 29(6)253–255
  • Fukal L. Spontaneous occurrence of ochratoxin by immunoassay. Dtsche. Lebensm. Rundsch. 1991; 87: 316–319
  • Fukal L. A survey of cereals, cereal products, feed stuffs and porcine kidneys for ochratoxin A by radioimmunoassay. Food Additives and contaminants 1990; 7: 253–258
  • Fukal L., Reisnerova H. Monitoring of aflatoxins and ochratoxin A in Czechoslovak human sera by immunoassay. Bull. Environ. Contam. Toxicol. 1990; 44: 345–349
  • Ruprich J., Ostry V. Study of human exposure to ochratoxin A and assessment of possible sources, Cent. Eur. J. Public Health 1993; 1(1)46–48
  • Malir F., Jergeova Z., Severa J., Cerna M., Smid J., Betbeder A. M., Baudrimont I., Creppy E. E. The level of ochratoxin A in blood serum of adults in the Czech Republic. Revue Méd. Vét. 1998; 149(6)710
  • Fournier E. Toxicologie. Nephrotoxines. Paris, Ellipses 1993; 473–485
  • Creppy E. E., Betbeder A. M., Gharbi A., Counord J., Castegnaro M., Bartsch H., Moncharmont P., Fouillet B., Chambon P., Dirheimer G. Human ochratoxicosis in France. Mycotoxins, Endemic Nephropathy and Urinary Tract Tumours, M. Castegnaro, R. Plestina, G. Dirheimer, I. N. Chernozemsky, H. Bartsch. 115 IARC Scientific Publications, IARC, Lyon 1991; 145–151
  • Recueil de protocoles pour l'analyse de l'ochratoxine A. Atelier de Travail International sur l'Ochratoxine A (UNESCO, FAO, IUPAC, ICSU), SousseTunisie, November, 14–171995. Faculté de Médecine, 1–28

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.